Skip to main content
BioSyent Inc. (TSXV: RX)
Canada flag Canada · Delayed Price · Currency is CAD
11.74
+0.10 (0.86%)
Dec 20, 2024, 3:58 PM EST

BioSyent Revenue

BioSyent had revenue of 9.56M CAD in the quarter ending September 30, 2024, with 7.72% growth. This brings the company's revenue in the last twelve months to 34.51M, up 12.12% year-over-year. In the year 2023, BioSyent had annual revenue of 31.59M with 13.12% growth.

Revenue (ttm)
34.51M
Revenue Growth
+12.12%
P/S Ratio
3.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
133.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202331.59M3.67M13.12%
Dec 31, 202227.93M-693.03K-2.42%
Dec 31, 202128.62M6.29M28.15%
Dec 31, 202022.33M907.84K4.24%
Dec 31, 201921.42M-102.70K-0.48%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch + Lomb Corporation 6.33B
Bausch Health Companies Inc. 12.80B
WELL Health Technologies Corp. 957.69M
Curaleaf Holdings, Inc. 1.83B
dentalcorp Holdings Ltd. 1.51B
Tilray Brands, Inc. 1.10B
Sienna Senior Living Inc. 867.55M
Cronos Group Inc. 150.26M
Revenue Rankings

BioSyent News

More News